作者
Trina Ekawati Tallei, Fatimawali, Nurdjannah Jane Niode, Rinaldi Idroes, BM Redwan Matin Zidan, Saikat Mitra, Ismail Celik, Firzan Nainu, Duygu Ağagündüz, Talha Bin Emran, Raffaele Capasso
发表日期
2021
来源
Evidence‐Based Complementary and Alternative Medicine
卷号
2021
期号
1
页码范围
7170736
出版商
Hindawi
简介
Green tea is produced from Camellia sinensis (L.) buds and leaves that have not gone through the oxidation and withering processes used to produce black and oolong teas. It was originated in China, but its cultivation and production have expanded to other Eastern Asian countries. Several polyphenolic compounds, including flavandiols, flavonols, flavonoids, and phenolic acids, are found in green tea and may constitute greater than 30% of the dry weight. Flavonols, especially catechins, represent the majority of green tea polyphenols. Green tea polyphenolic compounds have been reported to confer several health benefits. This review describes the potential use of green tea polyphenols in the management of coronavirus disease 2019 (COVID‐19). The immunomodulatory, antibacterial, antioxidant, and anti‐inflammatory effects of green tea polyphenols have also been considered in this review. In addition to …
学术搜索中的文章
TE Tallei, Fatimawali, NJ Niode, R Idroes, BMRM Zidan… - Evidence‐Based Complementary and Alternative …, 2021